Concepedia

Christoph Hallmann

CH

10

Publications

846

Citations

10

H-Index

1999

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (United States)

National Institute for Health Research

University of Southampton

NIHR Southampton Respiratory Biomedical Research Unit

Christoph Hallmann is an author at Boehringer Ingelheim (Germany) specializing in medicine, pulmonary disease, and acute lung injury.

Top concepts

Publications per year

1999–2018

10

Publications

10

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

Martin Kolb, Luca Richeldi, Jürgen Behr et al. · Thorax · 2016 · 227 citations · Full text

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial

Peter M.A. Calverley, Antonio Anzueto, Kerstine Carter et al. · The Lancet Respiratory Medicine · 2018 · 194 citations · Full text

, , +4

Tiotropium + olodaterol shows clinically meaningful improvements in quality of life

Dave Singh, Gary T. Ferguson, J Bolitschek et al. · Respiratory Medicine · 2015 · 171 citations · Full text

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis

Harold R. Collard, Luca Richeldi, Dong Soon Kim et al. · European Respiratory Journal · 2017 · 135 citations · Full text

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

Christine Winchester, David Halpin, Ronald E. Dahl et al. · International Journal of COPD · 2015 · 44 citations · Full text

Rows per page

1–5 of 10